Based on these results, gedunin suppressed cell growth and HSP client proteins, resulting in apoptosis in glioblastoma cell lines.<h4>Conclusion</h4>Our data provide in vitro support for the anticancer activity of gedunin in glioma cells by downregulating cancer survival proteins. The gene discussed is HSP90B2P; the disease is glioma.